logo
Select company
Select metric
$ 268.08MShareholders Equity
VS
Market
47
Sector
69
Industry
78
History
56
$ 9.87Close
$ 3.7 - $ 11.11 52-Week Range
Ticker Information

Ticker

GLUE

Company Name

MONTE ROSA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MONTE ROSA THERAPEUTICS INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GLUE - Equity Historical data
DateShareholders Equity
6/30/2025$ 268.08M
3/31/2025$ 275.16M
12/31/2024$ 222.94M
9/30/2024$ 205.46M
6/30/2024$ 224.67M
3/31/2024$ 152.52M
12/31/2023$ 179.25M
9/30/2023$ 184.52M
6/30/2023$ 213.65M
3/31/2023$ 243.73M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MONTE ROSA THERAPEUTICS INC's latest trailing twelve months (TTM) Equity stands at $ -48.73M.
  • Over the past 5 years, MONTE ROSA THERAPEUTICS INC's average Equity has been $ 227.61M.
  • The median Equity for MONTE ROSA THERAPEUTICS INC during this period was $ 243.73M
  • MONTE ROSA THERAPEUTICS INC reached its highest Equity over the past 5 years at $ 369.31M.
  • The lowest Equity recorded by MONTE ROSA THERAPEUTICS INC in the same timeframe $ -60.62M

MONTE ROSA THERAPEUTICS INC's Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Equity Benchmarks
CompanyEquity
VNDA : VANDA PHARMACEUTICALS INC $ 486.33MHRTX : HERON THERAPEUTICS INC $ -27.26MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ 231.05MCTMX : CYTOMX THERAPEUTICS INC $ 119.91MRGNX : REGENXBIO INC $ 213.68MMGNX : MACROGENICS INC $ 46.62MTRDA : ENTRADA THERAPEUTICS INC $ 379.5MPBYI : PUMA BIOTECHNOLOGY INC $ 104.72MCDXS : CODEXIS INC $ 55.63MSCPH : SCPHARMACEUTICALS INC $ -21.32M

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

GLUE - Shareholders Equity, Last 5 years

$ -60.62M

Minimum

Mar 31, 2021

$ 369.31M

Maximum

Sep 30, 2021

$ 227.61M

Average

$ 243.73M

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 383.73M with a standard deviation of $ 548.38M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 383.73M
median$ 165.6M
std$ 548.38M